Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Mackinnon

Showing results (51-60 of 130) with videos related to

Pageof 13
Sort By:
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|June 17, 2010
Supplementation with the antioxidant lycopene significantly decreases oxidative stress parameters and the bone resorption marker N-telopeptide of type I collagen in postmenopausal womenE S Mackinnon, A V Rao, R G Josse, et al.
Journal of Nutrigenetics and Nutrigenomics|July 29, 2010
Paraoxonase 1 polymorphisms 172T→A and 584A→G modify the association between serum concentrations of the antioxidant lycopene and bone turnover markers and oxidative stress parameters in women 25-70 years of ageE S Mackinnon, A El-Sohemy, A V Rao, et al.
Blood|June 14, 2000
Longitudinal monitoring of immune reconstitution by CDR3 size spectratyping after T-cell-depleted allogeneic bone marrow transplant and the effect of donor lymphocyte infusions on T-cell repertoireS Verfuerth, K Peggs, P Vyas, et al.
Biochimica Et Biophysica Acta|December 2, 2000
Polyphenolics enhance red blood cell resistance to oxidative stress: in vitro and in vivoK A Youdim, B Shukitt-Hale, S MacKinnon, et al.
Bone Marrow Transplantation|December 12, 2002
Alemtuzumab (Campath-1H) for treatment of lymphoid malignancies in the age of nonmyeloablative conditioning?G Hale, S Slavin, J M Goldman, et al.
International Journal of Women'S Health|October 13, 2016
Bone strength and management of postmenopausal fracture risk with antiresorptive therapies: considerations for women's health practiceAngela M Cheung, Heather Frame, Michael Ho, et al.
Bone Marrow Transplantation|November 24, 2004
Syndrome 'X' in adult female recipients of bone marrow transplantation for haematological malignanciesR Chatterjee, K Palla, H H McGarrigle, et al.
Bone Marrow Transplantation|April 28, 1999
Early PCR-negativity after allogeneic BMT in adults with t(4;11) ALL in the absence of acute or chronic GVHDS D'Sa, S Verfuerth, P Vyas, et al.
British Journal of Haematology|January 1, 1991
Origin and function of adherent lymphokine activated killer cells in patients with chronic myeloid leukaemia who relapse following bone marrow transplantationS Mackinnon, J Bungey, A Chase, et al.
Blood|December 15, 1992
Myeloid and lymphoid chimerism after T-cell-depleted bone marrow transplantation: evaluation of conditioning regimens using the polymerase chain reaction to amplify human minisatellite regions of genomic DNAS Mackinnon, L Barnett, J H Bourhis, et al.
Pageof 13

Showing results (51-60 of 130) with videos related to

Sort By:
Pageof 13
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|June 17, 2010
Supplementation with the antioxidant lycopene significantly decreases oxidative stress parameters and the bone resorption marker N-telopeptide of type I collagen in postmenopausal womenE S Mackinnon, A V Rao, R G Josse, et al.
Journal of Nutrigenetics and Nutrigenomics|July 29, 2010
Paraoxonase 1 polymorphisms 172T→A and 584A→G modify the association between serum concentrations of the antioxidant lycopene and bone turnover markers and oxidative stress parameters in women 25-70 years of ageE S Mackinnon, A El-Sohemy, A V Rao, et al.
Blood|June 14, 2000
Longitudinal monitoring of immune reconstitution by CDR3 size spectratyping after T-cell-depleted allogeneic bone marrow transplant and the effect of donor lymphocyte infusions on T-cell repertoireS Verfuerth, K Peggs, P Vyas, et al.
Biochimica Et Biophysica Acta|December 2, 2000
Polyphenolics enhance red blood cell resistance to oxidative stress: in vitro and in vivoK A Youdim, B Shukitt-Hale, S MacKinnon, et al.
Bone Marrow Transplantation|December 12, 2002
Alemtuzumab (Campath-1H) for treatment of lymphoid malignancies in the age of nonmyeloablative conditioning?G Hale, S Slavin, J M Goldman, et al.
International Journal of Women'S Health|October 13, 2016
Bone strength and management of postmenopausal fracture risk with antiresorptive therapies: considerations for women's health practiceAngela M Cheung, Heather Frame, Michael Ho, et al.
Bone Marrow Transplantation|November 24, 2004
Syndrome 'X' in adult female recipients of bone marrow transplantation for haematological malignanciesR Chatterjee, K Palla, H H McGarrigle, et al.
Bone Marrow Transplantation|April 28, 1999
Early PCR-negativity after allogeneic BMT in adults with t(4;11) ALL in the absence of acute or chronic GVHDS D'Sa, S Verfuerth, P Vyas, et al.
British Journal of Haematology|January 1, 1991
Origin and function of adherent lymphokine activated killer cells in patients with chronic myeloid leukaemia who relapse following bone marrow transplantationS Mackinnon, J Bungey, A Chase, et al.
Blood|December 15, 1992
Myeloid and lymphoid chimerism after T-cell-depleted bone marrow transplantation: evaluation of conditioning regimens using the polymerase chain reaction to amplify human minisatellite regions of genomic DNAS Mackinnon, L Barnett, J H Bourhis, et al.
Pageof 13